Abstract submission now open
TOP STORIES & SCIENTIFIC HIGHLIGHTS
A new year message from the EAACI President
Dear colleagues and friends, dear EAACI Family,
Happy 2020! At the onset of the New Year we wish you and your families a prosperous and healthy 2020.
In 2020 we would be happy to see you joining exciting developments in EAACI and taking the opportunity to share knowledge and the most recent developments in our field by attending the EAACI Annual Congress 2020, the largest allergy Congress held in London from 6 to 10 June, but also our focused meetings, master classes or allergy schools and a range of other topical events in our field.
2019 was very successful for the EAACI family worldwide – an international outreach network embracing a vast membership of over 12,000 dedicated researchers, clinicians, allied health professionals, National Allergy Societies, and Patient Organisations from all around the globe. Our Annual Congress in Lisbon broke a record number of participants as the largest ever Allergy Meeting, which provided an unparalleled scientific programme through which we “Mapped the New World of Allergy”.
This year, according to the motto of the 2020 congress "Bridging Innovations into Allergy and Asthma Prevention" the top scientists and physicians will present the most inspiring and creative ideas diffused and adapted to the needs of our patients.
In 2020 EAACI will continue to be the centre of excellence for state-of-the-art research on allergic diseases, asthma and clinical immunology and a hub providing support for training and career development within the fundamentally revolutionizing healthcare system, with the goal of improving peoples’ quality of life.
2020 will be a year with many new initiatives that can only be achieved with your support. We are currently working on an update of the EAACI Global Atlas of Asthma, the translation of the MAUG in Spanish, new Guidelines on biologicals, atopic dermatitis and AIT guidelines for allergy and asthma, and an update of the anaphylaxis and food allergy prevention guidelines. We have approved over 80 task forces that will start 2020 with exciting new mandates and will certainly yield comprehensive position papers in the coming year.
Our three EAACI journals, Allergy, PAI and CTA will continue to be in the spotlight as references for allergy experts and researchers with rapidly increasing impact factors positioning them in the top of scientific journals in our field.
A new EAACI Research platform aims to facilitate allergy, asthma and clinical immunology research through the coordination and support of the research community. High quality and reproducible data will be supported by leveraging resources into a joint information exchange network. Ultimately, it will boost top-notch experimental research through multi-centre collaboration and strengthen the validity of experimental medical results.
An innovative e-learning platform will provide the optimal conditions for Continuous Medical Education. Combining interactive e-learning modules (with webcasts, live streams, webinars, recommended reads and questionnaires), the platform will open numerous possibilities to acquire CME credits conveniently and from a reliable and renowned source.
The advocacy efforts in the EU will advance strongly: following the Parliamentary elections, and a successful reorganizing of the Interest Group on Allergy and Asthma. A meeting at the EU Parliament in November 2019 ensured discussions between EAACI Leadership, international organisations and MEPs on how to efficiently integrate allergy into Europe’s political agenda and beyond.
Advocating for allergy will be completed with the help and empowerment of patients and Patient organisations: EFA, our partner in activities at the EU level; our committed Patient organisation committee composed of 30 organisations; and our newly launched task forces dealing with public outreach.
We will have many opportunities to meet during 2020 at one of the activities of our Society. Although we provide digital opportunities, we do hope you will choose to come to one or more of our meetings. Please find here a calendar of events in 2020 on our website. One thing that cannot be substituted by modern developments in technology and remote e-tools is the richness gained through your personal interactions and networking.
EAACI is proud to invite you, along with numerous key opinion leaders to London, a city which offers unrivalled inventiveness and an enchanting scenery, where famous bridges connect people.
We would like to warmly thank for your continued support to the Academy and our common efforts to increase awareness and provide the best possible care to allergic patients.
We wish you a wonderful and rewarding year filled with success and happiness!
Marek Jutel, EAACI President
The EAACI Executive Committee and HQ Staff
The European Strategic Forum on Allergic Diseases
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision‐makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real‐world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.
Read the full manuscript here.
Read the full manuscript here.
EAACI WHITE PAPER
Committed to inscreasing allergy awareness and driving policy changes for improved patient care. The EAACI White Paper tackles research-innovation-quality of care nexus for allergic diseases and asthma.
Read here the EAACI White Paper
Read here the EAACI White Paper
GLOBAL ATLAS OF SKIN ALLERGY
The brand new Global Atlas of Skin Allergy is now available online in early release!!
Access it here.
The “Global Atlas of Skin Allergy” contains 113 chapters writtn by 118 authors with 92 clinical pictures, 105 illustratins and 70 tables. It covers the basics of skin immunology and mechanisms in the skin, epidemiology, nomenclature, histopathology, skin allergy tests as key elements for allergy diagnosis, the clinical pictures of cutaneous allergic reactins and diffrentil diagnoses, guidance on recognitin and management, a comprehensive global assessment of burden as well as
strategies for the management allergic skin diseases.
Access it here.
EAACI MEDIA LIBRARY - NEW CONTENT
Brand new content in the EAACI Media Library all OPEN ACCESS: We have now available on the Media Library all content from PAAM 2019